Volume 11, Issue 5 (Sep - Oct 2017)                   mljgoums 2017, 11(5): 33-35 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Komijani M, Kardi M T, Shahin K, Yazdi M. Detection of Mediterranean Hepatitis B in a 45 Years Old Man in Mahdieh Clinical Laboratory, Isfahan, Iran. mljgoums. 2017; 11 (5) :33-35
URL: http://mlj.goums.ac.ir/article-1-1016-en.html
1- Department of Biology, Faculty of Science, Arak University, Arak, Iran
2- Department of Microbiology, Mahdieh Laboratory, Isfahan, Iran , m.kardi@gmail.com
3- State Key Laboratory Cultivation Base of Most, Institute of Food Safety and Nutrition, Jiangusa Academy of Agricultural Sciences, Nanjing 210014,PR China
4- Department of Biology, Faculty of Sciences, University of Isfahan, 81746073441 Isfahan, IR Iran
Abstract:   (7370 Views)
          Three major hepatitis B virus (HBV) antigens include HBcAg, HBeAg and HBsAg. HBeAg is the extracellular form of HBcAg, and is seen almost exclusively in people who have circulating serum HBV DNA. Presence of HBsAg in serum indicates that the individual has contracted HBV infection. Chronic hepatitis HBeAg-negative/anti-HBe–positive is known as an important form of chronic hepatitis B in the Mediterranean region. In this report, we used Real-Time PCR and ELISA for detection of HBV and HBeAg/HbsAg, respectively. In our investigation on 4743 HBV cases referred to the Mahdieh Clinical Laboratory between 2008 and 2016, we found a 53-year-old man with clinical symptoms of hepatitis and abnormal molecular and serological features. Despite the presence of clinical symptoms and high viral load (128 × 105 iu/ml), the patient was HBsAg-positive and HBeAg-negative. Identifying this type of HBV could indicate spread of this type of hepatitis in Isfahan, Iran.
           Keywords: Hepatitis B, HbsAg, HBeAg.
Keywords: Hepatitis B, HbsAg, HBeAg.
Full-Text [PDF 392 kb]   (747 Downloads)    
Type of Study: Original Paper |
Received: 2017/11/15 | Accepted: 2017/11/15 | Published: 2017/11/15 | ePublished: 2017/11/15

1. Walsh R, Locarnini S. Hepatitis B precore protein: pathogenic potential and therapeutic promise. Yonsei Med J. 2012;53(5):875-85. doi: 10.3349/ymj.2012.53.5.875. [DOI:10.3349/ymj.2012.53.5.875]
2. McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology. 2009;49(S5). doi: 10.1002/hep.22898. [DOI:10.1002/hep.22898]
3. Krajden M, McNabb G, Petric M. The laboratory diagnosis of hepatitis B virus. Can J Infect Dis Med Microbiol. 2005; 16(2): 65-72. PMCID: PMC2095015. [DOI:10.1155/2005/450574]
4. Akahane Y, Yamanaka T, Suzuki H, Sugai Y, Tsuda F, Yotsumoto S, et al. Chronic active hepatitis with hepatitis B virus DNA and antibody against e antigen in the serum: disturbed synthesis and secretion of e antigen from hepatocytes due to a point mutation in the precore region. Gastroenterol. 1990; 99(4): 1113-9. [DOI:10.1016/0016-5085(90)90632-B]
5. Yoo BC, Park J-W, Kim HJ, Lee DH, Cha YJ, Park SM. Precore and core promoter mutations of hepatitis B virus and hepatitis B e antigen-negative chronic hepatitis B in Korea. J Hepatol. 2003; 38(1): 98-103. [DOI:10.1016/S0168-8278(02)00349-5]
6. McMahon BJ, Holck P, Bulkow L, Snowball M. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus. Ann Intern Med. 2001; 135(9): 759-68. [DOI:10.7326/0003-4819-135-9-200111060-00006]
7. Okamoto H, Yotsumoto S, Akahane Y, Yamanaka T, Miyazaki Y, Sugai Y, et al. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol. 1990; 64(3): 1298-303. PMID:2304145.2017; 10(1): 39-43.
8. Brunetto M. Identification of HBV variants which cannot produce pre-core derived HBeAg and may be responsible for severe hepatitis. Ital J Gastroenterol. 1989; 21: 151-4.
9. Carman W, Hadziyannis S, McGarvey M, Jacyna M, Karayiannis P, Makris A, et al. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. The Lancet. 1989; 334(8663): 588-91. [DOI:10.1016/S0140-6736(89)90713-7]
10. Hadziyannis SJ, Vassilopoulos D. Hepatitis B e antigen—negative chronic hepatitis B. Hepatology. 2001; 34(4): 617-24. [DOI:10.1053/jhep.2001.27834]
11. Naoumov NV, Schneider R, Grötzinger T, Jung MC, Miska S, Pape GR, et al. Precore mutant hepatitis B virus infection and liver disease. Gastroenterol. 1992; 102(2): 538-43. [DOI:10.1016/0016-5085(92)90101-4]
12. Sali S, Sharafi H, Alavian SH, Alavian SM, Etesam F, Salimi S, et al. Can serum level of HBsAg differentiate HBeAg-negative chronic hepatitis B from inactive carrier state? Diagnostic microbiology and infectious disease. 2015; 82(2): 114-9. doi: 10.1016/j.diagmicrobio.2015.02.005. [DOI:10.1016/j.diagmicrobio.2015.02.005]
13. Esmaeelzadeh A, Saadatnia H, Memar B, Amirmajdi EM, Ganji A, Goshayeshi L, et al. Evaluation of serum HBV viral load, transaminases and histological features in chronic HBeAg-negative hepatitis B patients. Gastroenterology and Hepatology from bed to bench.

Add your comments about this article : Your username or Email:

Send email to the article author

© 2007 All Rights Reserved | Medical Laboratory Journal